Partners,

Join Families USA in our next webinar, The Fight for Lower Drug Prices: How to Engage in Inflation Reduction Act Implementation on Wednesday, April 5 at 2pm ET to discuss how and when we can mobilize together to ensure that implementation of recent prescription drug pricing policies remains focused on truly lowering costs.

Families USA has also released a new advocacy resource to help our partners to engage in this process. It provides advocates with helpful information and background on the drug pricing provisions of the IRA, including a timeline of key dates when important public commenting opportunities will arise, an overview of the IRA’s statutory language, and a detailed outline of key regulatory decisions that are most important for advocates to engage with CMS and the Administration on.

The Inflation Reduction Act of 2022 (IRA) was a critical moment in the effort to achieve lower and more affordable drug costs. However, the fight does not end with this legislative victory because big drug corporations and their army of lobbyists have publicly indicated they will use every opportunity to weaken the law. To ensure the IRA truly results in lower drug prices for people who rely on Medicare, it is critical for health advocates to weigh in as the Biden Administration, and specifically the Centers for Medicare & Medicaid Services (CMS) within the Department of Health and Human Services, implements the law through regulatory and sub-regulatory processes.

We hope you can join and look forward to continuing to partner in this important work to lower the cost of prescription drugs!